Literature DB >> 18060641

Screening of differently expressed genes in human prostate cancer cell lines with different metastasis potentials.

Anping Song1, Guoning Liao, Mingfu Wu, Yunping Lu, Ding Ma.   

Abstract

In order to screen the genes differentially expressed in two human prostate cancer cells with different metastasis potentials, suppression subtractive hybridization (SSH) was done twice on human prostate cancer cell line with high potential of metastasis PC3M-1E8 and its synogenetic cell line PC3M-2B4 with low metastasis potential. In the first subtraction PC3M-2B4 was used as tester and PC3M-1E8 as driver and the forward subtractive library was constructed. In the second on the tester and driver were interchanged and the reverse subtractive library was constructed. The screened clones of both libraries were sequenced and Gene Bank homology search was performed. Some clones were confirmed by quantitative real-time PCR. The results showed that two subtractive libraries containing 238 positive clones were constructed. Analysis of 16 sequenced clones randomly picked from two libraries showed that 4 differentially expressed gene fragments were identified as new EST with unknown functions. It was concluded that two subtractive libraries of human prostate cancer cell lines with different metastasis potentials were constructed successfully.

Entities:  

Mesh:

Year:  2007        PMID: 18060641     DOI: 10.1007/s11596-007-0527-x

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  10 in total

1.  [Isolation and characterization of human prostate cancer cell subclones with different metastatic potential].

Authors:  Y Liu; J Zheng; W Fang; J You; J Wang; X Cui; B Wu
Journal:  Zhonghua Bing Li Xue Za Zhi       Date:  1999-10

2.  Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries.

Authors:  L Diatchenko; Y F Lau; A P Campbell; A Chenchik; F Moqadam; B Huang; S Lukyanov; K Lukyanov; N Gurskaya; E D Sverdlov; P D Siebert
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

Review 3.  Tumor progression and metastasis.

Authors:  J Yokota
Journal:  Carcinogenesis       Date:  2000-03       Impact factor: 4.944

4.  Angiogenesis-associated protein annexin II in breast cancer: selective expression in invasive breast cancer and contribution to tumor invasion and progression.

Authors:  Meena R Sharma; Lauren Koltowski; Robert T Ownbey; George P Tuszynski; Mahesh C Sharma
Journal:  Exp Mol Pathol       Date:  2006-04-27       Impact factor: 3.362

5.  Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migration.

Authors:  Jun-Wei Liu; Jian-Jun Shen; Angela Tanzillo-Swarts; Bobby Bhatia; Carlos M Maldonado; Maria D Person; Serrine S Lau; Dean G Tang
Journal:  Oncogene       Date:  2003-03-13       Impact factor: 9.867

6.  Activity, expression, and transcription rate of the cathepsins B, D, H, and L in cutaneous malignant melanoma.

Authors:  E Fröhlich; B Schlagenhauff; M Möhrle; E Weber; C Klessen; G Rassner
Journal:  Cancer       Date:  2001-03-01       Impact factor: 6.860

7.  Cathepsin B in infiltrated lymph nodes is of prognostic significance for patients with nonsmall cell lung carcinoma.

Authors:  B Werle; C Kraft; T T Lah; J Kos; U Schanzenbächer; K Kayser; W Ebert; E Spiess
Journal:  Cancer       Date:  2000-12-01       Impact factor: 6.860

8.  Tenascin C and annexin II expression in the process of pancreatic carcinogenesis.

Authors:  I Esposito; R Penzel; M Chaib-Harrireche; U Barcena; F Bergmann; S Riedl; H Kayed; N Giese; J Kleeff; H Friess; P Schirmacher
Journal:  J Pathol       Date:  2006-04       Impact factor: 7.996

9.  Expression and intracellular localization of FKHRL1 in mammary gland neoplasms.

Authors:  Gui-Shan Jin; Eisaku Kondo; Takayoshi Miyake; Masao Shibata; Takako Takashima; Yi-Xuan Liu; Kazuhiko Hayashi; Tadaatsu Akagi; Tadashi Yoshino
Journal:  Acta Med Okayama       Date:  2004-08       Impact factor: 0.892

Review 10.  FOXO factors: a matter of life and death.

Authors:  Haojie Huang; Donald J Tindall
Journal:  Future Oncol       Date:  2006-02       Impact factor: 3.404

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.